Brief: CytoTools Carries Out Phase II Study As Planned, Raises Stake In DermaTools

bioXXmed AG

08/03/2019 10:33

March 8 (Reuters) - CytoTools AG  T5OG.DE :
    * CARRIES OUT THE PHASE II STUDY AS PLANNED, FURTHER INCREASING ITS STAKE IN DERMATOOLS
    * SAYS DERMATOOLS CARRIES OUT CAPITAL INCREASE WITH CASH INFLOW AMOUNTING TO ABOUT EUR 1.7
MILLION
    * INCREASES ITS STAKE IN DERMATOOLS TO OVER 62%

Source text for Eikon:  ID:nEQ10rC8Pa 
Further company coverage:  T5OG.DE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))